BLRX Biotech
• Stem cell treatment for leukemia
• $75 million market cap, $16 million in cash
• Several products in pipeline offering potential catalysts
• $3.00 - $4.00 Upside
• $1.60 Downside
• Stem cell treatment for leukemia
• $75 million market cap, $16 million in cash
• Several products in pipeline offering potential catalysts
• $3.00 - $4.00 Upside
• $1.60 Downside